Related Experiment Video
Updated: Jun 12, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
[Management of chronic kidney disease in primary care: New practical guidelines in primary care]
Anna Silvano1, Paolo Di Taranto1, Sarah Fiorentini2
1Service de médecine de premier recours, Hôpitaux universitaires de Genève, 1211 Genève 14.
Insights
Chronic kidney disease (CKD) affects millions globally. New guidelines emphasize controlling cardiovascular risk factors, including using SGLT2 inhibitors, to slow CKD progression and prevent end-stage renal disease.
Area of Science:
- Nephrology
- Cardiology
- Public Health
Context:
- Chronic kidney disease (CKD) affects 8-16% of the global population, presenting significant clinical and public health challenges.
- CKD is associated with increased morbidity, mortality, and progression to end-stage renal failure requiring costly treatments like dialysis and transplantation.
- Managing cardiovascular risk factors is crucial for patients with CKD.
Purpose:
- To summarize the latest nephroprotection recommendations for primary care physicians.
- To highlight the importance of managing cardiovascular risk factors in CKD.
- To introduce emerging treatments like SGLT2 inhibitors for CKD management.
Summary:
- The article reviews current nephroprotection strategies for primary care.
- It emphasizes adherence to the latest KDIGO guidelines for CKD management.
- Focus is placed on optimizing cardiovascular risk factor control, particularly with SGLT2 inhibitors.
Impact:
- Provides primary care physicians with updated guidance on CKD management.
- Aims to improve patient outcomes by slowing CKD progression.
- Supports the integration of novel therapies like SGLT2 inhibitors into clinical practice for nephroprotection.
Abstract:
Chronic kidney disease is often encountered in clinical practice, affecting between 8 and 16% of the world's population. Screening for CKD represents a major challenge for patients, given the increase in morbidity and mortality associated with the disease, as well as a public health issue in terms of slowing the progression to end-stage renal failure, which requires costly replacement treatments (dialysis and transplantation). The new KDIGO guidelines suggest aiming for optimal control of the cardiovascular risk factors associated with chronic kidney disease, in particular with the help of emerging treatments such as SGLT2 inhibitors. This article summarises the latest nephroprotection recommendations for primary care physicians.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease I: Introduction
Acute Kidney Injury V: Interprofessional Care
Kidney Transplant III: Nursing Management
Nephrotic Syndrome III : Nursing Management

